| Literature DB >> 34558206 |
Yoshihiro Takada1,2, Tomoko Hanaoka1, Hidetaka Imagita1, Toshihide Yasui1,3, Daisuke Takeshita1, Masami Abe4, Shinnosuke Kawata1, Taku Yamakami1, Keisuke Okada1, Hiroe Washio5, Syunji Okuda1, Akira Minematsu1, Tomohiro Nakamura6, Shin Terada7, Takashi Yamada4, Akira Nakatani8, Susumu Sakata9.
Abstract
Diabetic skeletal muscles show reduced contractile force and increased fatigability. Hands are a target for several diabetes-induced complications. Therefore, reduced handgrip strength often occurs as a consequence of diabetes. The aim of this study was to examine whether long-term exercise can prevent reduction of grip strength in type 2 diabetes mellitus (T2DM) model OLETF rats, and to explore the mechanisms underlying diabetes-induced grip strength reduction. Ten 5-week-old OLETF rats were used as experimental animals, and five non-diabetic LETO rats as controls of OLETF rats. Half OLETF rats performed daily voluntary wheel-running for 17 months (OLETF + EXE), and the rest of OLETF and LETO rats were sedentary. Grip strength was higher in OLETF + EXE and LETO groups than in OLETF group. OLETF group with hyperglycemia showed an increase in HbA1c, serum TNF-α, and muscle SERCA activity, but a decrease in circulating insulin. Each fiber area, total fiber area, and % total fiber area in type IIb fibers of extensor digitorum longus muscles were larger in OLETF + EXE and LETO groups than in OLETF group. There was a positive correlation between grip strength and the above three parameters concerning type IIb fiber area. Therefore, type IIb fiber atrophy may be the major direct cause of grip strength reduction in OLETF group, although there seems multiple etiological mechanisms. Long-term wheel-running may have blocked the diabetes-induced reduction of grip strength by preventing type IIb fiber atrophy. Regular exercise may be a potent modality for preventing not only the progression of diabetes but muscle dysfunction in T2DM patients.Entities:
Keywords: OLETF rat; grip strength; type 2 diabetes mellitus; wheel-running exercise
Mesh:
Year: 2021 PMID: 34558206 PMCID: PMC8461031 DOI: 10.14814/phy2.15046
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
FIGURE 4Photograph of animal in the reverse (a) and vertical (b) hanging tests, and hanging time in the reverse (c) and vertical (d) hanging tests of three groups. Values are means + SD. Statistical comparisons between the groups were assessed by one‐way ANOVA followed up with Fisher's LSD post hoc analysis. *Significant difference (p < 0.05). Symbols represent data from individual animals. In both hanging tests, n = 4 in the OLETF group, and n = 5 in the OLETF + EXE and LETO groups. Effect sizes; reverse hanging test, 0.426; vertical hanging test, 0.200
Body mass, tibial length, blood glucose, and serum biochemical data
| OLETF + EXE | OLETF | LETO | Effect size | |
|---|---|---|---|---|
| Body mass (g) | 529 ± 43 | 496 ± 88 | 576 ± 18 | 0.286 |
| Tibial length (mm) | 45.7 ± 0.3 | 45.0 ± 0.8 | 45.8 ± 0.4 | 0.320 |
| Blood glucose (mg/dl) | 69 ± 26 | 234 ± 94 | 71 ± 12 | 0.651 |
| Total protein (g/dl) | 5.2 ± 0.3 | 5.3 ± 0.5 | 5.7 ± 0.2 | 0.229 |
| Total cholesterol (mg/dl) | 150 ± 15 | 255 ± 11 | 24 ± 6 | 0.962 |
Values are expressed as mean ± SD. N = 5 in each group.
Statistical comparisons between the groups were assessed by one‐way ANOVA followed by Fisher's LSD post hoc test.
Significantly different from the OLETF + EXE and LETO groups (p < 0.01)
Significantly different from the LETO group (p < 0.01)
Significantly different from the OLETF and LETO groups (p < 0.01).
FIGURE 1Weekly running distance. Five OLETF rats performed daily voluntary wheel‐running for a 17‐month period from age 5 weeks through age 74 weeks. (a) Individual changes in weekly running distance with aging (n = 5). (b) Changes in the mean weekly running distance with aging. Values are means ± SD (n = 5). Significant differences between the first week value and the latter values were determined using repeated‐measures ANOVA followed up with Sidak post hoc analysis. The overall p value obtained by repeated‐measures ANOVA is below 0.001. *Significantly different from the first week value (p < 0.01). #Significantly different from the first week value (p < 0.001)
FIGURE 2Serum levels of hemoglobin A1c (a), insulin (b) and tumor necrosis factor‐α (c) in three groups. Values are means + SD. Statistical comparisons between the groups were assessed by one‐way ANOVA followed up with Fisher's LSD post hoc analysis. *Significant difference (p < 0.05). #Significant difference (p < 0.01). Symbols represent data from individual animals, and the number in the parentheses represents the number of examined animals. Effect sizes; HbA1c, 0.840; insulin, 0.699; TNF‐α, 0.374. HbA1c, hemoglobin A1c; TNF‐α, tumor necrosis factor‐α
FIGURE 3Grip strength in three groups. Values are means + SD. Statistical comparisons between the groups were assessed by one‐way ANOVA followed up with Fisher's LSD post hoc analysis. *Significant difference (p < 0.05). Symbols represent data from individual animals. N = 4 in the OLETF group, and n = 5 in the OLETF+EXE and LETO groups. Effect size is 0.702
Muscle mass and the ratio of muscle weight to tibial length
| OLETF + EXE | OLETF | LETO | Effect size | |
|---|---|---|---|---|
| EDL mass (mg) | 220.5 ± 6.7 | 216.9 ± 28.8 | 257.9 ± 8.8 | 0.577 |
| EDL mass/TL (mg/mm) | 4.83 ± 0.15 | 4.82 ± 0.50 | 5.63 ± 0.19 | 0.585 |
| SOL mass (mg) | 188.9 ± 20.4 | 180.3 ± 34.6 | 233.6 ± 15.0 | 0.527 |
| SOL mass/TL (mg/mm) | 4.14 ± 0.42 | 4.00 ± 0.62 | 5.10 ± 0.31 | 0.522 |
| BB mass (mg) | 283.5 ± 8.7 | 268.9 ± 33.7 | 322.9 ± 21.4 | 0.539 |
| BB mass/TL (mg/mm) | 6.21 ± 0.15 | 5.97 ± 0.58 | 7.04 ± 0.38 | 0.560 |
| RF mass (mg) | 1480.2 ± 84.7 | 1440.0 ± 180.5 | 1630.2 ± 133.8 | 0.303 |
| RF mass/TL (mg/mm) | 32.4 ± 1.7 | 32.0 ± 3.1 | 35.6 ± 2.8 | 0.273 |
Values are expressed as mean ± SD. N = 5 in each group.
Statistical comparisons between the groups were assessed by one‐way ANOVA followed by Fisher's LSD post hoc test.
Abbreviations: BB, biceps brachii; EDL, extensor digitorum longus; RF, rectus femoris; SOL, soleus; TL, tibial length.
Significantly different from the LETO group (p < 0.05)
Significantly different from the LETO group (p < 0.01).
FIGURE 5Characterization of extensor digitorum longus muscle fibers in the three groups. Percent fiber number (a), each fiber area (b), total fiber area (c), and percent total fiber area (d) in the type I, type IIa, and type IIb fibers. Grey bars, the OLETF + EXE group; striped bars, the OLETF group; white bars, the LETO group. Values are means + SD. Statistical comparisons between the groups were assessed by one‐way ANOVA followed up with Fisher's LSD post hoc analysis. *Significant difference (p < 0.05). #Significant difference (p < 0.01). Symbols represent data from individual animals, and the value in the parentheses represents effect size. N = 5 in each group
FIGURE 6Sarcoplasmic reticulum Ca2+‐ATPase activity in the rectus femoris muscles from three groups. Values are means + SD. Statistical comparisons between the groups were assessed by one‐way ANOVA followed up with Fisher's LSD post hoc analysis. *Significant difference (p < 0.05). Symbols represent data from individual animals. N = 5 in each group. SERCA, sarcoplasmic reticulum Ca2+‐ATPase. Effect size is 0.351
Correlations between grip strength and various parameters
| r |
| |
|---|---|---|
| Body mass | 0.448 | 0.123 |
| Blood glucose | −0.819 | 0.001 |
| Hb A1c | −0.695 | 0.012 |
| Total protein | 0.001 | 0.998 |
| Total cholesterol | −0.775 | 0.002 |
| Insulin | 0.215 | 0.502 |
| TNF‐α | −0.684 | 0.020 |
| SERCA activity | −0.510 | 0.075 |
| EDL mass | 0.633 | 0.020 |
| SOL mass | 0.663 | 0.013 |
| BB mass | 0.600 | 0.030 |
| RF mass | 0.466 | 0.109 |
| %FN‐I | −0.636 | 0.019 |
| %FN‐IIa | 0.483 | 0.095 |
| %FN‐IIb | 0.285 | 0.345 |
| FA‐I | 0.379 | 0.201 |
| FA‐IIa | 0.566 | 0.044 |
| FA‐IIb | 0.773 | 0.002 |
| TFA‐I | −0.408 | 0.167 |
| TFA‐IIa | 0.560 | 0.047 |
| TFA‐IIb | 0.752 | 0.003 |
| %TFA‐I | −0.707 | 0.007 |
| %TFA‐IIa | 0.169 | 0.582 |
| %TFA‐IIb | 0.568 | 0.043 |
Pearson's correlation coefficients were calculated to determine the relation between grip strength and other measured parameters.
Abbreviations: %TFA, percent total fiber area; BB, biceps brachii; EDL, extensor digitorum longus; FA, fiber area; FN, fiber number; Hb A1c, hemoglobin A1c; RF, rectus femoris; SERCA, sarcoplasmic reticulum Ca2+‐ATPase; SOL, soleus; TFA, total fiber area; TNF‐α, tumor necrosis factor‐α.
OLETF + EXE group is compared with the OLETF and LETO groups in terms of various parameters
| Measurements | Vs. OLETF group | Vs. LETO group |
|---|---|---|
| Body size parameters | ||
| Body mass |
|
|
| Tibial length |
|
|
| Diabetic parameters | ||
| Blood glucose |
|
|
| HbA1c |
|
|
| Serum biochemical parameters | ||
| Insulin |
|
|
| TNF‐α |
|
|
| Total protein |
|
|
| Total cholesterol |
|
|
| Grip strength and hanging capacity | ||
| Grip strength |
|
|
| Reverse hanging capacity |
|
|
| Vertical hanging capacity |
|
|
| Muscle mass and SERCA activity | ||
| Muscle mass (EDL, SOL, BB) |
|
|
| Muscle mass/TL (EDL, SOL, BB) |
|
|
| SERCA activity (RF) |
|
|
| EDL muscle fiber properties | ||
| %FN‐I |
|
|
| %FN‐IIa |
|
|
| %FN‐IIb |
|
|
| FA‐I |
|
|
| FA‐IIa |
|
|
| FA‐IIb |
|
|
| TFA‐I |
|
|
| TFA‐IIa |
|
|
| TFA‐IIb |
|
|
| %TFA‐I |
|
|
| %TFA‐IIa |
|
|
| %TFA‐IIb |
|
|
HbA1c, hemoglobin A1c; TNF‐α, tumor necrosis factor‐α; SERCA, sarcoplasmic reticulum Ca2+‐ATPase; EDL, extensor digitorum longus; SOL, soleus; BB, biceps brachii; RF, rectus femoris; TL, tibial length; FN, fiber number; FA, fiber area; TFA, total fiber area.
, no difference; , significant increase; , significant decrease; , increase without statistical significance; , decrease without statistical significance.